ABeta amyloidosis, Arctic type
ORPHA: 3247231 Treatment Available
Overview
Hereditary cerebral hemorrhage with amyloidosis (HCHWA), Arctic type is a form of HCHWA (see this term) characterized by an age of onset of 54-61 years and progressive Alzheimer's disease-like dementia, without intracerebral hemorrhages
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Patisiran Orphan Cold Chain | IV infusion, 2 mg/mL | FDA Approved | 6 | — |
Clinical Presentation
Signs and symptoms associated with ABeta amyloidosis, Arctic type, sourced from HPO and Orphanet clinical annotations.
Atypical behaviorFebrile seizure (within the age range of 3 months to 6 years)
Classification & Codes
Orphanet Code
ORPHA:324723ABeta amyloidosis, Arctic type
| Orphanet | ORPHA:324723 |
| Treatments | 1 drug(s) |
| Symptoms on record | 2 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO